2013
DOI: 10.1002/ana.23955
|View full text |Cite
|
Sign up to set email alerts
|

Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease

Abstract: Low content of mtDNA in CSF may be a novel biomarker for the early detection of preclinical AD. These findings support the hypothesis that mtDNA depletion is a characteristic pathophysiological factor of neurodegeneration in AD.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

12
146
1

Year Published

2014
2014
2020
2020

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 181 publications
(165 citation statements)
references
References 24 publications
12
146
1
Order By: Relevance
“…In support of this, induction of mitochondrial fragmentation with Phen, a DNA-damaging agent, leads to a decline in the mitochondrial DNA content and loss of mitochondrial mass in HeLa cells (33). Similarly to the findings in FECD specimens, a low content of mtDNA has been detected in the cerebrospinal fluid of Alzheimer's disease patients and has been postulated to be a causal factor for mitochondrial-driven neurodegenerative processes (34).…”
Section: Discussionmentioning
confidence: 72%
“…In support of this, induction of mitochondrial fragmentation with Phen, a DNA-damaging agent, leads to a decline in the mitochondrial DNA content and loss of mitochondrial mass in HeLa cells (33). Similarly to the findings in FECD specimens, a low content of mtDNA has been detected in the cerebrospinal fluid of Alzheimer's disease patients and has been postulated to be a causal factor for mitochondrial-driven neurodegenerative processes (34).…”
Section: Discussionmentioning
confidence: 72%
“…7 d). The gene for 18S ribosomal RNA was used as a control for the total amount of genomic DNA in the reaction [27] . Unfortunately, all 4 colonies selected were heterozygous; only 1 of the RANK genes cleaved while preserving the intact gene in the other homologous chromosome.…”
Section: Development Of a Stable Bv2 Rank -/-Cell Line Using Crispr/cmentioning
confidence: 99%
“…CSF isoprostanes correlate to clinical disease progression in the MCI and dementia stages of AD, especially in APOE e4-carrying patients [166], and may serve as damage response markers. Pilot studies suggest that the levels of oxidative DNA damage repair products are elevated in CSF from mixed vascular and Alzheimer's dementia patients [167], and that reduced levels of mitochondrial DNA in CSF suggest depletion of mitochondria [168], which may reflect oxidative stress, but these studies await replication.…”
Section: Biomarkers For Inflammation Oxidative Stress and Microgliamentioning
confidence: 99%